Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Marketing Strategy of Brens Bakery Business in Manna City of South Bengkulu Regency Sari, Endah Permata; Herfianti, Meiffa; Ferina, Zahrah Indah
Journal of Indonesian Management Vol. 1 No. 3 (2021): SEPTEMBER
Publisher : Penerbit Jurnal Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53697/jim.v1i3.167

Abstract

The purpose of this study is to determine the marketing strategy of Brens Bakery business in Manna city, South Bengkulu Regency. According to Assuari (2010: 168), marketing strategy is basically a comprehensive, integrated and unified plan in the marketing field, which provides guidance on activities to be carried out to achieve the marketing objectives of a company. The sample in this study were 51 people consisting of 6 employees of the Brens Bakery Business in Manna City, South Bengkulu Regency for internal factors and 45 people for external factors, namely customers at Brens Bakery Business in Manna City, South Bengkulu Regency. The analysis method used was SWOT analysis, which consists of the Internal Strategy Factor Matrix (IFAS) and the External Strategy Factor Matrix (EFAS). The results showed that the marketing strategy of Brens Bakery Business in Manna City, South Bengkulu Regency supported the aggressive strategy, or SO strategy in SWOT matrix. The result of strengths are 18.52 while the weaknesses are 9.24, so the internal quadrant of the factors is 18.52 - 9.24 = 9.28. It means that the ability of Brens Bakery Business in Manna City, South Bengkulu Regency in utilizing strengths and minimizing weaknesses contained in the internal company. The opportunity of this strategy are 17.40 and threat is 10.48. So the external quadrant factor, namely 17.40 - 10.48 = 6.92 means the high ability of Brens Bakery Business in Manna City, South Bengkulu Regency in taking advantage of opportunities and overcoming threats faced by companies in marketing bread
The Value of the TB IgG/IgM Rapid Test and Erythrocyte Sedimentation Rate in Relation to Xpert MTB/RIF Tests in the Diagnosis of Pulmonary Tuberculosis Sari, Endah Permata; Lutpiatina, Leka; Insana, Aima
Tropical Health and Medical Research Vol. 8 No. 1 (2026): Tropical Health and Medical Research
Publisher : Baiman Bauntung Batuah Center

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Tuberculosis (TB) remains a global health problem, requiring healthcare workers to have accurate and effective diagnostic methods. The Xpert MTB/RIF-based Molecular Rapid Test is recommended as the standard for TB diagnosis, but in clinical practice, healthcare workers still frequently use the TB IgG/IgM Rapid Test and the Erythrocyte Sedimentation Rate (ESR) as complementary tests. This study aimed to determine the relationship between Xpert MTB/RIF test results and the TB IgG/IgM Rapid Test and ESR in pulmonary tuberculosis patients at Pertamina Hospital, Balikpapan. This study used a retrospective, observational analytical study design utilizing secondary data from laboratory tests from January–December 2024. Researchers analyzed data from 250 patients who met the inclusion criteria. They analyzed the relationship between variables using the Spearman correlation test. The results showed that 16.4% of patients had MTB detected on the Xpert MTB/RIF test. Statistical analysis showed a significant positive correlation between Xpert MTB/RIF results and the TB IgG/IgM Rapid Test, with a moderate correlation strength (r = 0.562; p < 0.001). Furthermore, the analysis also showed a significant correlation between Xpert MTB/RIF results and ESR (r = 0.183; p = 0.004), but with a very weak correlation strength. The majority of patients with MTB detected by Xpert MTB/RIF had positive TB IgG/IgM Rapid Test results and abnormal ESR values. This study shows that the TB IgG/IgM Rapid Test and ESR are associated with Xpert MTB/RIF results. However, both tests have limited specificity and can therefore only be used as supporting tests and cannot replace molecular testing in the diagnosis of pulmonary tuberculosis.